By not following the precision medicine trend for its new lung cancer drug, the Wall Street Journal writes that Bristol-Myers Squibb has outmaneuvered its rivals like Merck.
...and receive Daily News bulletins.
Already have an account?Login Now.
A new report highlights the potential threats posed by advances in synthetic biology, NPR reports.
A Bloomberg reporter tried to get her genetic data deleted, but found it's not so simple to do.
Johns Hopkins University's Steven Salzberg and his colleagues have come up with a new estimate for the number of human genes, Nature News reports.
In Genome Research this week: study of intra-tumor heterogeneity, workflow resources for EPIGEN-Brazil, and more.